pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
Transforming growth factor-beta (TGF-beta) inhibits cell proliferation by inducing a G1-phase cell cycle arrest. Normal progression through G1 is promoted by the activity of the cyclin-dependent protein kinases CDK4 and CDK6 (ref. 2), which are inhibited by the protein p16INK4. We have isolated a new member of the p16INK4 family, p15INK4B. p15 expression is induced approximately 30-fold in human keratinocytes by treatment with TGF-beta, suggesting that p15 may act as an effector of TGF-beta-mediated cell cycle arrest. The gene encoding p15 is located on chromosome 9 adjacent to the p16 gene at a frequent site of chromosomal abnormality in human tumours (9p21).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to p16INK4A, p15INK4B has been shown to an effector of TGF-β meditated cell cycle arrest by inhibiting CDK4/6 (Hannon and Beach, 1994).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Hannon and Beach, 1994
In the citing paper
“Within months of its discovery, the INK4a (CDKN2A) and the genetically linked INK4b gene (CDKN2B) (36) were implicated in a reverse genetic screen to play tumor suppressive roles in familial melanoma (37).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [36]
Citations
Cites
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.
Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., & Fusenig, N. E. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.3.761 · Cited by 4,170
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
The Transforming Growth Factor-beta Family
Massague, J. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.003121 · Cited by 3,015
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
Sherr, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90636-5 · Cited by 1,960
Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Research works printed but not linked: 7
- Bates, S. et al. Oncogene 9, 71–79 (1994).
- Merlo, A., Gabrielson, E., Askin, F. & Sidransky, D. Cancer Res. 54, 640–642 (1994).
- Cheng, J. Q., Jhanwar, S. C., Lu, Y. Y. & Testa, J. R. Cancer Res. 53, 4761–4763 (1993).
- Petty, E. M. et al. Am. J. hum. Genet. 53, 96–104 (1993).
- Moses, H. L. et al. in Cancer Cells (eds Feramisco, J., Ozanne, B. & Stiles, C.) 3, 65–71 (1985).
- Manning, A. M., Williams, A. C., Gamie, S. M. & Paraskeva, C. Oncogene 6, 1471–1476 (1991).
- Rodeck, U. et al. Cancer Res. 54, 575–581 (1994).
Cited by
Items 1,001–1,003 of 1,003
Genome-wide transcriptome profiling of human trabecular meshwork cells treated with TGF-β2
Callaghan, B., Lester, K., Lane, B., Fan, X., Goljanek-Whysall, K., Simpson, D. A., Sheridan, C., & Willoughby, C. E. (2022) · Scientific Reports · doi:10.1038/s41598-022-13573-8 · Cited by 27
“TGF-β inhibits cell proliferation by producing G1 phase cell cycle arrest and CDKN2B, which forms a complex with either CDK4 or CDK6 preventing their activation, acts as an effector of TGF-β cell cycle arrest 45 .”
Functional inactivation of thyroid transcription factor-1 in PCCl3 thyroid cells
Christophe-Hobertus, C., Lefort, A., Libert, F., & Christophe, D. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.02.013 · Cited by 15
Cellular senescence and cancer
(1999) · doi:10.1002/(sici)1096-9896(199901)187:1
Metadata
- Authors
- Hannon, G. J., & Beach, D.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Hannon, Gregory J.
- Venue
- Nature
- Published
- 1994-09
- Volume
- 371
- Issue
- 6494
- Pages
- 257-261
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003907692
- Cited by
- 1,950
- References
- 29
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 26 · 2023: 26 · 2022: 22 · 2021: 30 · 2020: 18 · 2019: 42 · 2018: 29 · 2017: 24 · 2016: 37 · 2015: 48 · 2014: 37 · 2013: 44 · 2012: 54
- FWCI
- 51.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- CDKN2B, p16INK4, TGF-beta, cell cycle arrest, G1 phase, CDK4, CDK6, cyclin-dependent kinases, keratinocytes, 9p21, tumor suppressor, chromosome 9
- MeSH terms
- Amino Acid Sequence, Base Sequence, Carrier Proteins, Cell Cycle, Cell Line, Cloning, Molecular, Humans, Molecular Sequence Data, Proto-Oncogene Proteins, RNA, Messenger, Keratinocytes, Gene Expression, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cyclin-Dependent Kinases, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Proteins, Cyclin-Dependent Kinase Inhibitor p15, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.